Perturbations of the endometrial immune microenvironment in endometriosis and adenomyosis: their impact on reproduction and pregnancy
Seminars in Immunopathology · 2025-12 · 47 (1)
DOI: 10.1007/s00281-025-01040-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 18.02.2025. Verfasst von Jialu Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Endometriosis, Adenomyosis, Endometrium, Reproduction. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CUHK Direct Grant.
Abstract (Originalsprache)
The impact of endometriosis and adenomyosis on reproduction and pregnancy is significant, with both conditions linked to increased rates of infertility, poor ovarian function in women with endometriosis, and elevated pregnancy complications in those with adenomyosis. However, the underlying mechanisms remain largely unclear. Both conditions share a similar pathophysiological process characterized by the growth of ectopic endometrium, which may originate from the eutopic endometrium. Notably, surgical removal of ectopic lesions does not appear to significantly improve reproductive and pregnancy outcomes, further underscoring the importance of eutopic endometrium in these adverse effects. Emerging evidence indicates substantial differences in endometrial NK cells, macrophages, and T cells, leading to inflammatory responses in women with endometriosis and adenomyosis. These alterations may contribute not only to disease progression but also to defective endometrial receptivity, insufficient angiogenesis remodeling, impaired maternal-fetal immune tolerance, and poor placentation, thereby influencing embryo implantation and pregnancy maintenance. This provides an immunological perspective to explain the higher rates of infertility and pregnancy complications observed in affected women. Therefore, we systematically review the alterations in endometrial immune cells in women with endometriosis and adenomyosis compared to healthy controls, exploring the potential impacts of these changes on reproduction and pregnancy. This review aims to lay the groundwork for future studies on the immunopathogenesis associated with endometriosis and adenomyosis-related reproductive failure and pregnancy complications, shedding lights on the development of immunotherapeutic strategies to mitigate these adverse impacts in affected women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China. taozhang@cuhk.edu.hk.
- Joint Laboratory in Reproductive Medicine, Chinese University of Hong Kong, Sichuan University, The Chinese University of Hong Kong, Hong Kong, China. taozhang@cuhk.edu.hk.
Förderung
- National Natural Science Foundation of China
- CUHK Direct Grant
Zitieren
APA
Shi, J., Xu, Q., Yu, S., & Zhang, T. (2025). Perturbations of the endometrial immune microenvironment in endometriosis and adenomyosis: their impact on reproduction and pregnancy. Seminars in Immunopathology, 47(1). https://doi.org/10.1007/s00281-025-01040-1
Vancouver
Shi J, Xu Q, Yu S, Zhang T. Perturbations of the endometrial immune microenvironment in endometriosis and adenomyosis: their impact on reproduction and pregnancy. Seminars in Immunopathology. 2025;47(1). doi:10.1007/s00281-025-01040-1
BibTeX
@article{Shi2025,
author = {Shi, Jialu and Xu, Qianhan and Yu, Shuyi and Zhang, Tao},
title = {Perturbations of the endometrial immune microenvironment in endometriosis and adenomyosis: their impact on reproduction and pregnancy},
journal = {Seminars in Immunopathology},
year = {2025},
volume = {47},
number = {1},
doi = {10.1007/s00281-025-01040-1}
}
EUVIMED